Package Insert: Information for the Patient
TENSIKEY COMPLEX 20 mg/12.5 mg Tablets
Lisinopril/Hydrochlorothiazide
Read this entire package insert carefully before starting to take this medication, as it contains important information for you.
1. What is TENSIKEY COMPLEX 20 mg/12.5 mg Tablets and what it is used for
2. What you need to know before starting to take TENSIKEY COMPLEX 20 mg/12.5 mg Tablets
3. How to take TENSIKEY COMPLEX 20 mg/12.5 mg Tablets
4. Possible adverse effects
5. Storage of TENSIKEY COMPLEX 20 mg/12.5 mg Tablets
6. Contents of the package and additional information
TENSIKEY COMPLEX 20 mg/12.5 mg tablets are an anti-hypertensive medication (to lower blood pressure).
TENSIKEY COMPLEX 20 mg/12.5 mg tablets contain two active ingredients: lisinopril, an anti-hypertensive that belongs to the family of "Angiotensin-Converting Enzyme Inhibitors (ACEIs)" and hydrochlorothiazide, a diuretic (urine-producing medication) that belongs to the family of thiazides. Both compounds have complementary mechanisms of action and exert an additional anti-hypertensive effect.
Do not take Tensikey Complex 20 mg/12.5 mg tablets:
Warnings and precautions:
Consult your doctor or pharmacist before starting to take Tensikey Complex 20 mg/12.5 mg tablets:
- After the first dose, as you may experience a significant drop in blood pressure. If you experience a drop in blood pressure after the first or second dose or when increasing the dose, consult your doctor.
- If you have any of the following conditions or situations, you need to adjust the dose to avoid excessive and sudden drops in blood pressure:
- If you have renal or hepatic function alterations (such as renal artery stenosis or progressive liver disease),
- If you are taking any of the following medications used to treat high blood pressure (hypertension):
- An angiotensin II receptor antagonist (ARA) (also known as "sartans" - for example, valsartan, telmisartan, irbesartan), particularly if you have renal problems related to diabetes.
- Aliskiren
Your doctor may monitor your renal function, blood pressure, and electrolyte levels in your blood (such as potassium) at regular intervals.
See also the information under the heading "Do not take Tensikey Complex 20 mg/12.5 mg tablets".
- Before taking this medication, inform your doctor if you have had a kidney transplant or require hemodialysis.
- Before being anesthetized or undergoing surgery, inform your doctor or anesthesiologist if you are taking this medication, as it may cause a sudden drop in blood pressure.
- Before undergoing parathyroid function tests, inform your doctor if you are taking this medication.
- If you experience swelling of the face, lips, mouth, tongue, and/or larynx, or difficulty breathing, discontinue treatment and seek immediate medical attention.
- If you are undergoing desensitization treatment due to an allergy (for example, insect bite).
- If you have systemic lupus erythematosus, as this medication may reactivate or worsen symptoms.
- If you have insulin-dependent diabetes, initiate treatment with low doses and under medical supervision, and may require adjustment of antidiabetic medications, including insulin. This is because this medication may alter glucose tolerance.
- If you experience a decrease in vision or eye pain, they may be symptoms of fluid accumulation in the vascular layer of the eye (choroidal effusion) or increased intraocular pressure, which can occur within a few hours to a week after taking Tensikey Complex 20 mg/12.5 mg tablets. This can cause permanent vision loss if not treated. If you have previously had an allergy to penicillin or sulfonamide, you may be at higher risk of developing this.
Use of other medications
Inform your doctor or pharmacist if you are taking, or have recently taken, any other medication, including those purchased without a prescription.
This is because Tensikey Complex 20 mg/12.5 mg tablets may affect the way some medications work, and some medications may have an effect on Tensikey Complex 20 mg/12.5 mg tablets. Your doctor may need to modify your dose and/or take other precautions.
You should never take a medication on your own initiative without your doctor's recommendation, as some combinations should be avoided.
Tensikey Complex 20 mg/12.5 mg tablets should not be administered simultaneously with:
- Tubocurarine, as thiazides, such as hydrochlorothiazide, may increase its response.
Nonsteroidal anti-inflammatory drugs (NSAIDs), used to treat symptoms such as fever, pain, and inflammation.
Consult your doctor or pharmacist before taking this medication.
ACE inhibitors (the group to which this product belongs) may cause fetal damage and death when administered during the second and third trimesters of pregnancy. If pregnancy is detected, administration of this medication should be discontinued as soon as possible. |
This medication is excreted in breast milk. In general, treatment should be interrupted or breastfeeding discontinued.
Driving and operating machinery
No studies have been conducted on the effect of this medication on driving ability. This medication may occasionally cause dizziness, vertigo, and fatigue, so be aware of this when driving vehicles or operating machinery.
Important information about some components of Tensikey Complex 20 mg/12.5 mg tablets
Warning to athletes: This medication contains a component that may result in a positive analytical result for doping control.
Follow exactly the administration instructions of this medication as indicated by your doctor. In case of doubt, consult your doctor or pharmacist again.
Remember to take your medication.
Your doctor will indicate the duration of treatment with TENSIKEY COMPLEX 20 mg/12.5 mg tablets. Do not discontinue treatment beforehand, as you may experience alterations in your blood pressure.
If you estimate that the action of TENSIKEY COMPLEX 20 mg/12.5 mg tablets is too strong or weak, inform your doctor or pharmacist.
The tablets are for oral administration.
Swallow the tablets with a sufficient amount of liquid – a glass of water.
The dose is 1 or 2 tablets per day, administered in a single dose.
TENSIKEY COMPLEX 20 mg/12.5 mg tablets should be taken approximately at the same time every day.
Essential Hypertension
The usual dose is 1 tablet once a day, taken approximately at the same time every day.
Generally, if the desired therapeutic effect cannot be achieved within a period of 2 to 4 weeks with this dosage, the dose can be increased to 2 tablets once a day.
Patients with Renal Insufficiency
TENSIKEY COMPLEX 20 mg/12.5 mg tablets should not be used as initial treatment in any patient with renal insufficiency.
In patients with mild renal insufficiency (creatinine clearance of >30 and <80
Previous Treatment with Diuretics
If you have received previous treatment with diuretics, consult your doctor before taking TENSIKEY COMPLEX 20 mg/12.5 mg tablets
Use in Children
Do not recommend treatment in children.
Use in the Elderly
Consult your doctor if you have any kidney problems, as you may need a dose adjustment.
If you take more TENSIKEY COMPLEX 20 mg/12.5 mg tablets than you should:
If you have taken more than you should, consult your doctor or pharmacist immediately. The most frequent symptoms are: feeling of dizziness, fatigue, and vertigo, due to sudden or excessive decrease in blood pressure (hypotension), dehydration, weakness, and decreased urine production due to renal insufficiency. The patient should be hospitalized for administration of appropriate treatment.
In case of overdose or accidental ingestion, consult the Toxicological Information Service. Phone (91) 562 04 20.
If you forgot to take TENSIKEY COMPLEX 20 mg/12.5 mg tablets:
Do not take a double dose to compensate for the missed doses.
Like all medicines, TENSIKEY COMPLEX 20 mg/12.5 mg tablets can cause side effects, although not everyone will experience them.
The majority of side effects of TENSIKEY COMPLEX 20 mg/12.5 mg tablets are mild and temporary.
Occasionally, a complex of symptoms may occur, including one or more of the following situations:
Fever, vasculitis (venous inflammation), myalgia (muscle pain), arthralgia/arthritis (joint pain/inflammation), a positive ANA test, skin rash, photosensitivity (sensitivity to light), blood abnormalities such as elevated erythrocyte sedimentation rate, eosinophilia, and leukocytosis, or other dermatological manifestations.
Decreased vision or eye pain due to high pressure [possible signs of fluid accumulation in the vascular layer of the eye (choroidal hemorrhage) or acute angle-closure glaucoma].
Some laboratory parameters may be altered, and this should be taken into account when performing tests.
Stop taking TENSIKEY COMPLEX 20 mg/12.5 mg tablets and immediately contact your doctor in any of the following situations:
Reporting of adverse effects
If you experience any type of adverse effect, consult your doctor, pharmacist, or nurse, even if it is a possible adverse effect that does not appear in this prospectus. You can also report them directly through the Spanish System for the Pharmacovigilance of Medicines for Human Use: https://www.notificaram.es. By reporting adverse effects, you can contribute to providing more information on the safety of this medicine.
Keep this medication out of the reach and sight of children.
No special storage conditions are required.
Medicines should not be disposed of through drains or in the trash. Dispose of the packaging of unused medicines at your local pharmacy's designated collection point (symbol). If in doubt, ask your pharmacist how to dispose of unused packaging and medicines. By doing so, you will help protect the environment.Do not use TENSIKEY COMPLEX 20 mg/12.5 mg tablets after the expiration date appearing on the box.
Composition of TENSIKEY COMPLEX 20 mg/12.5 mg tablets
The active principles: each tablet contains 20 mg of lisinopril (DCI) (anhydrous) and 12.5 mg of hydrochlorothiazide (DCI).
The other components (excipients) are: mannitol (E-421), anhydrous calcium hydrogen phosphate, cornstarch, pregelatinized cornstarch, and magnesium stearate.
Appearance of the product and content of the packaging
TENSIKEY COMPLEX 20 mg/12.5 mg tablets are presented in the form of tablets in packs of 28 units. The tablets are white, round, biconvex with a fracture line.
Holder of the marketing authorization and responsible for manufacturing
Holder of the marketing authorization
PHARMINICIO, S.L.
Paseo de La Habana, 9-11
28036 MADRID
Responsible for manufacturing
Laboratorio GENERFARMA, S.L.
C/ Isaac Peral 6 – Parque tecnológico
46980 Paterna – Valencia
Last review date of this leaflet: August 2022.
The detailed and updated information on this medication is available on the website of the Spanish Agency for Medicines and Medical Devices (AEMPS) http://www.aemps.gob.es/
Have questions about this medication or your symptoms? Connect with a licensed doctor for guidance and personalized care.